After $750 Price Hike Per Pill, Rival Drug Company Offers $1 Alternative
Well, guess who just came to the rescue for thousands of patients who were being forced to pay $750, instead of the earlier $13?
A rival drug company CEO who just announced his company would begin to offer the pill for just a dollar.
Martin Shkreli, 32, an American hedge fund manager and founder of Turing Pharmaceuticals, purchased the marketing rights to the life-saving drug called Daraprim for $55 million this summer. There were virtually no competing manufacturers for the drug, which is used to treat patients with toxoplasmosis, some cancers, and AIDS, when Turing became the sole supplier in August and raised the price.
http://www.goodnewsnetwork.org/after-pill-price-hike-rival-ceo-offers-dollar-alternative/